Literature DB >> 23536431

Dysfunction of protein homeostasis in myotonic dystrophies.

Giovanni Meola1, Karlie Jones, Christina Wei, Lubov T Timchenko.   

Abstract

Neuromuscular diseases Myotonic Dystrophies type 1 and type 2 (DM1 and DM2) are caused by unstable CTG and CCTG repeat expansions and have highly complex molecular mechanisms. DM1 is caused by the expansion of CTG repeats in the 3' UTR of the gene coding for Dystrophia Myotonica-Protein Kinase (DMPK). In DM2, intronic CCTG repeats are located in a gene encoding the Zinc Finger Protein 9 (ZNF9, also known as Cellular Nucleic Acid Binding Protein, CNBP). Both expansions cause pathologies through RNA CUG and CCUG repeats, which have toxic effects on the processing of many RNAs in the patients' tissues. The pathogenic role of CUG and CCUG repeats in the mis-regulation of alternative splicing, mediated by RNA-binding proteins CUGBP1 and MBNL1, has been discussed in a number of excellent reviews. Recent reports suggest that mutant RNA repeats affect several other RNA-binding proteins such as Staufen1 and the DEAD-box RNA helicase p68 (DDX5). Since CUGBP1, Staufen1 and p68 have many functions in cytoplasm, including regulation of protein translation, it is predicted that the alterations of these proteins in DM cells might have a toxic effect on global protein turnover. In this mini-review, we will summarize observations showing the role of RNA-binding proteins, CUGBP1 and ZNF9, in protein turnover in DM1 and in DM2. We will also discuss a possible role of misbalanced protein turnover in the age-dependent progression of DM1 and in a late onset of DM2.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23536431     DOI: 10.14670/HH-28.1089

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  9 in total

Review 1.  P68 RNA helicase as a molecular target for cancer therapy.

Authors:  Ting-Yu Dai; Liu Cao; Zi-Chen Yang; Ya-Shu Li; Li Tan; Xin-Ze Ran; Chun-Meng Shi
Journal:  J Exp Clin Cancer Res       Date:  2014-08-24

2.  Reduction of toxic RNAs in myotonic dystrophies type 1 and type 2 by the RNA helicase p68/DDX5.

Authors:  Karlie Jones; Christina Wei; Benedikt Schoser; Giovanni Meola; Nikolai Timchenko; Lubov Timchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-15       Impact factor: 11.205

Review 3.  Molecular mechanisms in DM1 - a focus on foci.

Authors:  Olof Joakim Pettersson; Lars Aagaard; Thomas Gryesten Jensen; Christian Kroun Damgaard
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

4.  Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction.

Authors:  Mouli Chakraborty; Estela Selma-Soriano; Emile Magny; Juan Pablo Couso; Manuel Pérez-Alonso; Nicolas Charlet-Berguerand; Ruben Artero; Beatriz Llamusi
Journal:  Dis Model Mech       Date:  2015-10-29       Impact factor: 5.758

5.  Functional KCa1.1 channels are crucial for regulating the proliferation, migration and differentiation of human primary skeletal myoblasts.

Authors:  Rajeev B Tajhya; Xueyou Hu; Mark R Tanner; Redwan Huq; Natee Kongchan; Joel R Neilson; George G Rodney; Frank T Horrigan; Lubov T Timchenko; Christine Beeton
Journal:  Cell Death Dis       Date:  2016-10-20       Impact factor: 8.469

6.  (CCUG)n RNA toxicity in a Drosophila model of myotonic dystrophy type 2 (DM2) activates apoptosis.

Authors:  Vildan Betul Yenigun; Mario Sirito; Alla Amcheslavky; Tomek Czernuszewicz; Jordi Colonques-Bellmunt; Irma García-Alcover; Marzena Wojciechowska; Clare Bolduc; Zhihong Chen; Arturo López Castel; Ralf Krahe; Andreas Bergmann
Journal:  Dis Model Mech       Date:  2017-06-16       Impact factor: 5.758

Review 7.  Of Mice and Men: Advances in the Understanding of Neuromuscular Aspects of Myotonic Dystrophy.

Authors:  Sandra O Braz; Julien Acquaire; Geneviève Gourdon; Mário Gomes-Pereira
Journal:  Front Neurol       Date:  2018-07-10       Impact factor: 4.003

8.  Dosage effect of multiple genes accounts for multisystem disorder of myotonic dystrophy type 1.

Authors:  Qi Yin; Hongye Wang; Na Li; Yifu Ding; Zhenfei Xie; Lifang Jin; Yan Li; Qiong Wang; Xinyi Liu; Liuqing Xu; Qing Li; Yongjian Ma; Yanbo Cheng; Kai Wang; Cuiqing Zhong; Qian Yu; Wei Tang; Wanjin Chen; Wenjun Yang; Fan Zhang; Chen Ding; Lan Bao; Bin Zhou; Ping Hu; Jinsong Li
Journal:  Cell Res       Date:  2019-12-18       Impact factor: 25.617

9.  Liver Proliferation Is an Essential Driver of Fibrosis in Mouse Models of Nonalcoholic Fatty Liver Disease.

Authors:  Ashley Cast; Meenasri Kumbaji; Amber D'Souza; Katherine Rodriguez; Anita Gupta; Rebekah Karns; Lubov Timchenko; Nikolai Timchenko
Journal:  Hepatol Commun       Date:  2019-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.